Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

KRX/002720 stock hub

KRX/002720 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

KRX/002720is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

91.9B

Korea Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

KRX/002720

In the news

Latest news · KRX/002720

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 9.8P50 17.1P75 31.9

Trailing P/E16.1

P25 12P50 23.1P75 39.5

ROE6.1

P25 -17.1P50 0.7P75 8.5

ROIC4.9

P25 -9P50 1.3P75 6.8

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All KRX/002720 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

227

Groups with data

Currency

KRW

Showing 227 of 227 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	South Korea
Country code	KR
Employees	248
Enterprise value	KRW 111.6B
Exchange	Korea Stock Exchange
Financial currency	KRW
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	KR7002720001
Last refreshed	2026-05-10
Market cap	KRW 91.9B
Price	KRW 4,515
Price currency	KRW
Rev Per Employee	707,646,062.46x
Sector	Healthcare
Sic	2834
Symbol	krx/002720
Website	https://www.kukjepharm.co.kr

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	6.2%
EV Earnings	19.59x
EV/EBIT	18.05x
EV/EBITDA	11.86x
EV/FCF	50.37x
EV/Sales	0.64x
FCF yield	2.41%
P/B ratio	0.94x
P/E ratio	16.12x
P/S ratio	0.52x
PE Ratio3 Y	58.99x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	3.52%
EBITDA Margin	5.36%
FCF margin	1.26%
Gross margin	53.36%
Gross Profit	KRW 93.6B
Gross Profit Growth	13.52%
Gross Profit Growth Q	-0.8%
Gross Profit Growth3 Y	13.97%
Gross Profit Growth5 Y	7.64%
Net Income	KRW 5.7B
Net Income Growth	9.46%
Net Income Growth Years	2%
Net Income Growth3 Y	17%
Net Income Growth5 Y	20.93%
Pretax Margin	3.67%
Profit Margin	3.25%
Profit Per Employee	KRW 23M
Profitable Years	2
ROA	2.22
Roa5y	1.12
ROCE	5.14
ROE	6.09
Roe5y	0.84
ROIC	4.87
Roic5y	2.03

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	1.18%
Cagr15y	7.97%
Cagr1y	-0.49%
Cagr3y	-0.78%
Cagr5y	-7.32%
Div CAGR10	13.93%
Div CAGR3	0%
Div CAGR5	2.97%
EPS Growth	9.38
EPS Growth Years	2
EPS Growth3 Y	16.83
EPS Growth5 Y	20.84
FCF Growth	115.42%
FCF Growth3 Y	-24.96%
OCF Growth	48.11%
OCF Growth3 Y	-3.55%
OCF Growth5 Y	2.73%
Revenue Growth	12.17x
Revenue Growth Q	4.09x
Revenue Growth Quarters	11x
Revenue Growth Years	4x
Revenue Growth3 Y	11.51x
Revenue Growth5 Y	6.12x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	KRW 1.01
Assets	KRW 182.3B
Cash	KRW 10.7B
Current Assets	KRW 67.4B
Current Liabilities	KRW 62B
Debt	KRW 30.4B
Debt EBITDA	KRW 3.23
Debt Equity	KRW 0.31
Debt FCF	KRW 13.72
Equity	KRW 97.7B
Interest Coverage	6.81
Liabilities	KRW 84.6B
Long Term Assets	KRW 114.9B
Long Term Liabilities	KRW 22.6B
Net Cash	KRW -19.7B
Net Cash By Market Cap	KRW -21.41
Net Debt EBITDA	KRW 2.09
Net Debt Equity	KRW 0.2
Net Debt FCF	KRW 8.88
Tangible Book Value	KRW 96.3B
Tangible Book Value Per Share	KRW 4,742
WACC	5.52

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.09
Inventory Turnover	3.39
Net Working Capital	KRW 24.7B
Quick ratio	0.63
Working Capital	KRW 5.4B
Working Capital Turnover	KRW 10.39

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.08%
Dividend Growth	0%
Dividend Growth Years	5%
Dividend per share	KRW 30
Dividend Years	2
Dividend Yield	0.66%
Ex Div Date	2026-03-12
Last Dividend	KRW 30
Payout Ratio	10.72%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	12.46%
1Y total return	-0.49%
200-day SMA	4,584.9
3Y total return	-2.33%
50-day SMA	4,844.9
50-day SMA vs 200-day SMA	50over200
5Y total return	-31.62%
All Time High	14,987.6
All Time High Change	-69.88%
All Time High Date	2020-08-20
All Time Low	661.3
All Time Low Change	582.77%
All Time Low Date	2008-10-28
ATR	144.6
Beta	0.4
Beta1y	-0.07
Beta2y	-0.04
Ch YTD	5
High	4,575
High52	5,470
High52 Date	2026-02-27
High52ch	-17.46%
Low	4,475
Low52	4,050
Low52 Date	2026-01-15
Low52ch	11.48%
Ma50ch	-6.81%
Price vs 200-day SMA	-1.53%
RSI	36.18
RSI Monthly	45.86
RSI Weekly	45.3
Sharpe ratio	-0.2x
Sortino ratio	-0.06
Total Return	0.59%
Tr YTD	5.65
Tr15y	215.87%
Tr1m	-4.75%
Tr1w	-4.14%
Tr3m	-0.92%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	KRW 6.2B
Operating Income Growth	-7.71
Operating Income Growth3 Y	5.46
Operating Income Growth5 Y	0.47
Operating margin	3.52

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	12,708,115%
Net Borrowing	816,006,000
Shares Insiders	12.69%
Shares Institutions	6.21%
Shares Out	20,362,502
Shares Qo Q	-0.27%
Shares Yo Y	0.08%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	KRW 2.2B
Average Volume	181,290.9x
Bv Per Share	4,810.4
CAPEX	KRW -3.6B
Ch10y	9.84
Ch15y	203
Ch1m	-4.75
Ch1w	-4.14
Ch1y	-1.1
Ch3m	-1.53
Ch3y	-3.53
Ch5y	-32.46
Ch6m	9.32
Change	0.56%
Change From Open	0.67
Close	4,490
Days Gap	-0.11
Depreciation Amortization	3,226,331,000
Dollar Volume	308,681,520
Earnings Date	2026-04-02
EBIT	KRW 6.2B
EBITDA	KRW 9.4B
EPS	KRW 280
F Score	6
FCF	KRW 2.2B
FCF EV Yield	1.99x
FCF Per Share	KRW 109
Financing CF	343,871,020
Fiscal Year End	December
Founded	1,959
Graham Number	5505.06703
Graham Upside	21.93
Income Tax	KRW 738.5M
Investing CF	-4,156,181,010
Is Primary Listing	1
Last Earnings Date	2025-11-13
Last Report Date	2025-12-31
Last Split Date	2023-03-17
Last Split Type	Forward
Lynch Fair Value	KRW 5,861
Lynch Upside	29.8
Ma150	4,536
Ma150ch	-0.46%
Ma20	4,767.3
Ma20ch	-5.29%
Net CF	2,024,807,650
Open	4,485
P FCF Ratio	41.48
P OCF Ratio	15.75
Payment Date	2026-04-21
Position In Range	40
Ppne	98,442,802,110
Price Date	2026-05-08
Price EBITDA	KRW 9.77
Ptbv Ratio	0.95
Relative Volume	0.38x
Revenue	175,496,223,490x
Tax By Revenue	0.42x
Tax Rate	11.46%
Tr6m	10%
Volume	68,368
Z Score	1.87

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

KRX/002720 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.7%

$30.0 annual per share

Payout ratio

+10.7%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+3.0%

5 consecutive years of growth

Total shareholder yield

+0.6%

Next ex-dividend date: 2026-03-12

Performance

KRX/002720 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns KRX/002720?

Insider, institutional, and short-interest positioning.

Institutional ownership

+6.2%

Share of float held by funds and institutions

Insider ownership

+12.7%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.1%

Negative means the company is buying back shares.

Technical

KRX/002720 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

36.2

Neutral momentum band

Price vs 200-day MA

-1.5%

50/200-day relationship not available

Beta (5Y)

0.40

Less volatile than the market

Sharpe ratio

-0.20

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About KRX/002720

Hub-level FAQ points readers to the deeper analysis pages.

What is the current krx/002720 stock rating?

krx/002720 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full krx/002720 analysis?

The full report lives at /stocks/krx/002720/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for krx/002720?

The latest report frames krx/002720 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the krx/002720 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.